ASCO Genitourinary Cancers Symposium
ASCO GU 2022 on Pembro as Post-Nephrectomy Adjuvant Therapy for RCC: Results From the 30-Month Follow-Up of the KEYNOTE-564
By
ASCO Genitourinary Cancers Symposium
FEATURING
Toni Choueiri
By
ASCO Genitourinary Cancers Symposium
FEATURING
Toni Choueiri
Login to view comments.
Click here to Login